Possibility of Cancer-Stem-Cell-Targeted Radioimmunotherapy for Acute Myelogenous Leukemia Using 211At-Cxcr4 Monoclonal Antibody

Scientific Reports - United Kingdom
doi 10.1038/s41598-020-63557-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Radioimmunotherapy of Malignancy Using Antibody Targeted Radionuclides

British Journal of Cancer
Cancer ResearchOncology
1986English

CXCR4 Regulates Migration and Development of Human Acute Myelogenous Leukemia Stem Cells in Transplanted NOD/SCID Mice

Cancer Research
Cancer ResearchOncology
2004English

CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma?

Biology
ImmunologyMolecular BiologyGeneticsBiochemistryMicrobiology Biological SciencesAgricultural
2020English

New Agents for Acute Myelogenous Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

HLA-Matched and HLA-Haploidentical Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia With T (16;21) (P11.2;q22)

Journal of Hematopoietic Cell Transplantation
2020English

Very Late Relapse of Chronic Myelogenous Leukemia Following Stem Cell Transplant

Hematology & Transfusion International Journal
2015English

BETP Degradation Simultaneously Targets Acute Myelogenous Leukemia Stem Cells and the Microenvironment

Journal of Clinical Investigation
Medicine
2019English

Concomitant Renal Cell Carcinoma and Chronic Myelogenous Leukemia: Utilization of a Targeted Approach

Current Oncology
Oncology
2009English

Acute Myeloid Leukemia Stem Cells and CD33-targeted Immunotherapy

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy